Press ESC to close

Dr. Agarwal's Health Care IPO

  • 5 minutes read
  • 1,010 Views

Dr. Agarwal's Health Care IPO        

IPO Details                                      Status: Closed 

Docs  DRHP View                         Subscription :1.48x  

Bidding Dates  

29 Jan '25 - 31 Jan '25  

Minimum Investment  

₹13,370 / 1 Lot (35Shares)  

Price Range  

₹382- ₹402  

Listing Gain  

₹48 

Fresh Issue                Offer for Sale      

300.00 Cr                     2727.26 Cr  

Issue Size  

₹3027.26 Cr  

Face Value  

₹ 01  

GMP  

40  _10%  

Listing AT  

NSE,BSE  

IPO Timeline  

IPO Opening Date    

Jan 29, 2025  

IPO Closing Date    

Jan 31, 2025  

Basis of Allotment    

Feb 03, 2025  

Initiation of Refunds    

Feb 04, 2025  

IPO Listing Date    

Feb 05, 2025  

Dr. Agarwal's Health Care Subscription Details  

Date  

QIB  

NII  

Retail  

EMPOthers

Total  

28-01-202500.040.10.070.060.07
29-01-20250.950.100.220.160.360.39
30-01-20254.410.390.400.260.481.48

Dr. Agarwal's Health Care IPO Reservation  

Investor Category  

Shares Offered  

QIB Shares    

50%  

Retail Shares    

35%  

NII (HNI) Shares    

15%  

Dr. Agarwal's Health Care Financial Information  

Period Ended  

30-09-2024

31-03-2024  

31-03-2023  

31-03-2022  

Assets3393.412752.821825.171026.13
Revenue837.941376.451031.39713.78
Profit After Tax39.5695.05103.2343.16

About Dr. Agarwal's Health Care  

Dr. Agarwal's Health Care Limited is an eye care services provider that provides a wide range of eye treatments, such as consultations, pharmaceutical goods, and cataract and refractive procedures. Because of its "hub-and-spoke" business strategy, the organisation may expand geographically and use resources more effectively. The spoke denotes primary and secondary facilities, while the hub is the tertiary facility. The BSE-listed subsidiary, Dr. Agarwal's Eye Hospital, was founded in 1994 and is owned by Dr. Agarwal's Health Care.  

The corporation has 193 facilities in 14 states and 4 union territories in India as of September 30, 2024, which includes 165 spokes and 28 hubs. It operates sixteen sites in nine African nations. The business had a 25% market share in India's organized eye care service chain in FY24.  

737 physicians work for the company across all of its locations. In FY24, the business conducted 220,523 procedures and served 21 lakh patients. In FY24, the hospital had 64.20% of its total revenue from surgeries, 12.83% from the sale of optical products, contact lenses, and accessories, and the remaining portion from the sale of pharmaceuticals connected to eye care  

Since FY20, the company has added facilities in Punjab, Tamil Nadu, and Mumbai, totaling more than 60. The organization runs three Centres of Excellence (COEs) that provide cutting-edge surgical skills and educational opportunities.  

Dr. Agarwal's Health Care IPO Objectives  

The company's proposed use of the issue's net proceeds is as follows:  

Repayment and prepayment of borrowings: The business will utilize ₹195.00 crores to fully or partially repay and prepay some of its borrowings.   

 

General Corporate Purposes and Inorganic Acquisition: A portion of the issue's gross proceeds, up to 25%, will be allocated to general corporate requirements or unspecified inorganic acquisitions.     

Dr. Agarwal's Health Care IPO: Strengths  

  1. In FY2024, Dr. Agarwal's Health Care Limited, an eye care chain, had a 25% market share and 1.7 times the sales of the second-largest competitor. With 193 sites in India and 16 in nine African nations, it guarantees a broad patient base.  

  2. Established in 1994, Dr. Agarwal's Eye Hospital is a subsidiary of Dr. Agarwal's Health Care, which also manages the operations of the listed company. The company owns 71.9% of the hospital.  

  3. Complete eye care services, including surgery, non-surgical care, consultations, diagnostics, and pharmaceutical and optical goods all under one roof.  

  4. With the help of integrated pharmacies, optical counters, and sophisticated surgical capabilities, standardized operating procedures across facilities guarantee reliable, superior patient experiences.  

Dr. Agarwal's Health Care IPO: Risks  

  1. Reliance on retainership contracts with physicians may have an impact on patient volumes, service quality, and financial outcomes in the event of terminations or retention issues.  

  2. The business works in a regulated field, and breaking safety, health, environmental, or other rules could lead to fines, delays, and other negative effects.  

  3. The company's 120 out of 193 facilities in Tamil Nadu, Maharashtra, and Karnataka account for 42.19% of its revenue in the first half of FY25. Negative changes in these states may have an adverse effect on the financial and business performance of companies.  

  4. Complaints against the business have included arbitration and disagreements with physicians on non-compete clauses, which may result in penalties, increased compliance expenses, and disruptions to business operations.     
       

How To Apply for Dr. Agarwal's Health Care   IPO Online?  

  1. Click and Login to Your Angel One Account   : Open the Angel One app or website and log in with your credentials.  

  2. Locate the IPO Section: Navigate to the 'IPO' section on the platform.  

  3. Select IPO: Find and select the Laxmi Dental IPO from the list of open IPOs.  

  4. Enter the Lot Size: Specify the number of lots you want to bid for.  

  5. Submit Your UPI ID: Enter your UPI ID to link your payment method and submit your application.  

  6. Approve Funds: Once you receive the bid request on your UPI app, approve it by entering your UPI PIN.  

Important Link          

Dr. Agarwal's Health Care IPO allotment status  

John Smith

Miss, this here ought to be.

Leave a comment

Your email address will not be published. Required fields are marked *